In the summer of 2020 we are opening our doors to a group of ambitious and perceptive students from the University of Cambridge.

Working in a small team of peers, with support from our industry experts, you will have two weeks dedicated to creating solutions to some of the biggest business challenges facing the pharmaceutical industry, including: 

  • How technology, such as artificial intelligence, could optimise clinical trial programmes?
  • How the application of new diagnostic tools and devices can support patients and optimise care?
  • How new business processes can create a sustainable, partnership driven future for the pharmaceutical industry?

At the end of the two-week challenge, your team will present their ideas to senior leaders in the business. Each team and candidate will receive extensive feedback from their mentors throughout.

If you’re up for the challenge, we want to hear from you.

How to apply:

The Innovation Challenge will run between 21st September to 2nd October 2020 and is open to individuals and teams (up to 5 people).

Applications are open to all students studying at the University of Cambridge, however, academic disciplines of natural sciences, medicine, computing science, engineering, behavioural science and economics will be particularly relevant.

Applicants should send their expression of interest to by 14th February 2020.

Within your email please provide a brief CV (one A4 side preferred) and answer the following questions:

  1. Why would you be suitable? (150 words max)
  2. What would you hope to gain from participating? (150 words max)

Teams entering should provide individual CVs and individual answers for questions. 

Successful candidates and teams will receive a decision by the end of March 2020.

Support and expenses

Napp will offer expenses of up to £20 per day and vouchers for breakfast and lunch at our staff restaurants. Should you have any further expense or support needs we are happy to discuss this on a case-by-case basis.

Date of preparation: December 2019 UK/CORP-19043e